Order Article Reprints

Zamboglou C, Spohn SKB, Adebahr S, Huber M, Kirste S, Sprave T, Gratzke C, Chen RC, Carl EG, Weber WA, et al. PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial. Cancers. 2021; 13(22):5795. https://doi.org/10.3390/cancers13225795

Zamboglou, Constantinos, Simon K. B. Spohn, Sonja Adebahr, Maria Huber, Simon Kirste, Tanja Sprave, Christian Gratzke, Ronald C. Chen, Ernst Günther Carl, Wolfgang A. Weber, and et al. 2021. "PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial" Cancers 13, no. 22: 5795. https://doi.org/10.3390/cancers13225795

Zamboglou, C., Spohn, S. K. B., Adebahr, S., Huber, M., Kirste, S., Sprave, T., Gratzke, C., Chen, R. C., Carl, E. G., Weber, W. A., Mix, M., Benndorf, M., Wiegel, T., Baltas, D., Jenkner, C., & Grosu, A. L. (2021). PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial. Cancers, 13(22), 5795. https://doi.org/10.3390/cancers13225795